Physician profile
Clifford E Howell
NPI 1295700458
$16,916.83
in general payments reported to CMS, 2019-2025
23 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $3,302 · 2021: $428 · 2022: $214 · 2023: $2,147 · 2024: $149 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,509 · Food and Beverage: $919.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,509.13 |
| Food and Beverage | $919.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,274.31 | 2019-2024 | Da Vinci Surgical System |
| Atricure, INC. | $2,188.86 | 2019-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Edwards Lifesciences Corporation | $372.92 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $292.36 | 2021-2022 | |
| Abbott Laboratories | $179.02 | 2019-2025 | Gallant |
| Zimmer Biomet Holdings, INC. | $118.98 | 2019 | |
| Endologix LLC | $86.75 | 2019 | |
| Angiodynamics, INC. | $70.65 | 2022-2025 | Angiovac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $49.73 | 2023-2024 | Lifevest |
| Getinge USA Sales, LLC | $37.84 | 2019 | |
| Abiomed | $31.91 | 2022 | |
| Livanova USA, INC. | $30.09 | 2019 | |
| Merck Sharp & Dohme LLC | $26.56 | 2022 | |
| Kestra Medical Technology Services, INC. | $21.31 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.71 | 2023 | Jardiance |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $16.89 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $16.58 | 2023 | Camzyos |
| Kls-Martin L.P. | $16.29 | 2022 | |
| Ethicon US, LLC | $15.87 | 2025 | Stratafix, Harmonic, Echelon Flex |
| Astrazeneca Pharmaceuticals LP | $14.61 | 2021 | |
| Ge Healthcare | $13.88 | 2022 | |
| Veran Medical Technologies, INC. | $13.69 | 2019 | |
| Medtronic, INC. | $9.02 | 2024 | Penditure |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clifford Howell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.